{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T22:57:35Z","timestamp":1752101855027},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Incidental tracer uptake on DOTATATE PET is increasingly encountered in clinical practice. We describe 3 patients with suspected or known neuroendocrine tumor who were found to have diffuse and intense stomach uptake on DOTATATE PET. All patients underwent esophagogastroduodenoscopy and\/or endoscopic ultrasound; the cause of the stomach uptake was attributed to proton-pump inhibitor use, chronic gastritis, and gastrinoma, respectively. These 3 cases highlight that diffuse and intense stomach DOTATATE uptake can be a benign finding probably attributed to proton-pump inhibitor use, chronic gastritis, or gastrinoma.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003153","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:23:09Z","timestamp":1601500989000},"page":"813-816","source":"Crossref","is-referenced-by-count":3,"title":["Three Cases of Diffuse, Intense Stomach Uptake on DOTATATE PET"],"prefix":"10.1097","volume":"45","author":[{"given":"Martin S.","family":"Auerbach","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and Department of Molecular and Medical Pharmacology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph R.","family":"Pisegna","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology and Parenteral Nutrition, Department of Veterans Affairs"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Kim","sequence":"additional","affiliation":[{"name":"Vatche and Tamar Manoukian Division of Digestive Diseases"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Run","family":"Yu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, UCLA David Geffen School of Medicine, Los Angeles, CA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1148\/rg.352140164","article-title":"Somatostatin receptor imaging with 68Ga DOTATATE PET\/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation","volume":"35","year":"2015","journal-title":"Radiographics"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0000000000001100","article-title":"Spectrum of 68Ga-DOTA TATE uptake in patients with neuroendocrine tumors","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41574-019-0168-8","article-title":"Function and mechanisms of enteroendocrine cells and gut hormones in metabolism","volume":"15","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/j.ijsu.2014.05.017","article-title":"The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report","volume":"12","year":"2014","journal-title":"Int J Surg"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"E2444","DOI":"10.3390\/ijms20102444","article-title":"The enterochromaffin-like [ECL] cell-central in gastric physiology and pathology","volume":"20","year":"2019","journal-title":"Int J Mol Sci"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"E5128","DOI":"10.3390\/ijms20205128","article-title":"Insights into effects\/risks of chronic hypergastrinemia and lifelong PPI treatment in man based on studies of patients with Zollinger-Ellison syndrome","volume":"20","year":"2019","journal-title":"Int J Mol Sci"},{"key":"bib7-20230925","first-page":"123","article-title":"Effects of Helicobacter pylori infection and long-term proton pump inhibitor use on enterochromaffin-like cells","volume":"25","year":"2012","journal-title":"Ann Gastroenterol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1053\/j.gastro.2008.05.021","article-title":"Control of gastric acid secretion in health and disease","volume":"134","year":"2008","journal-title":"Gastroenterology"},{"key":"bib9-20230925","first-page":"821","article-title":"Treatment of ECL cell carcinoids with octreotide LAR","volume":"39","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/1450-1147.136699","article-title":"False-positive (111)In-pentetreotide uptake in gastritis","volume":"12","year":"2013","journal-title":"World J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003153","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:18:21Z","timestamp":1695622701000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003153","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,26]]}}}